Position in ALDX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$4,132,919
+$1,760,176 QoQ
Shares Held
1,940,338
+38.2% QoQ
Ownership
3.22%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#5
of 108 holders
Holding Since
Mar 2021
22 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ALDX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026D. E. Shaw & Co., Inc. holds $5,017,559,982 across 217 Biotechnology names. ALDX ranks #104 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INSM |
INSMED Inc
|
5,877,959 | $626,707,987 | |
| 2 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
1,104,109 | $332,369,932 | |
| 3 | EXEL |
Exelixis, Inc.
|
5,551,747 | $302,070,554 | |
| 4 | BBIO |
BridgeBio Pharma, Inc.
|
3,633,007 | $270,586,360 | |
| 5 | TGTX |
Tg Therapeutics, Inc.
|
3,400,808 | $186,840,390 | |
| 6 | HALO |
Halozyme Therapeutics, Inc.
|
2,006,479 | $157,047,110 | |
| 7 | AXSM |
Axsome Therapeutics, Inc.
|
604,753 | $148,025,391 | |
| 8 | PTCT |
Ptc Therapeutics, Inc.
|
1,548,919 | $126,345,322 |
All Filings in ALDX
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,132,919 | 1,940,338 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $2,372,743 | 1,403,990 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $8,294,858 | 1,601,324 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $7,202,780 | 1,379,843 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $1,867,783 | 487,672 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $871,941 | 151,642 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $941,028 | 188,583 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $1,804,469 | 334,781 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $1,065,614 | 321,938 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $1,790,782 | 547,640 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $912,796 | 260,056 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $307,059 | 45,967 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $637,472 | 75,980 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $1,240,475 | 124,922 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $2,421,168 | 347,869 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $2,392,907 | 448,110 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $1,090,630 | 273,341 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $1,063,057 | 239,158 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $144,912 | 36,228 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $125,387 | 14,281 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $172,476 | 15,223 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $215,645 | 18,152 | Shares | Defined | 2021-05-17 | |
| No filing history on record for this holder in this stock. | ||||||